BC Week In Review | Oct 5, 2015
Clinical News

EML4-ALK assay: Clinical trial data

An analysis of plasma samples from 24 patients with stage IV NSCLC with known anaplastic lymphoma kinase (ALK) tissue status determined by fluorescence in situ hybridization (FISH) showed that Exosome’s ExoDx Lung ALK assay had...
BC Week In Review | Apr 27, 2015
Clinical News

EML4-ALK assay: Clinical trial data

An analysis of blood samples from 29 patients with NSCLC showed that Exosome’s EML4-ALK assay had 100% specificity for differentiating between the 3 major fusion transcript variants of EML4-ALK. No false positives were detected. Exosome...
Items per page:
1 - 2 of 2